Plectasin

WikiDoc Resources for Plectasin
Articles
Most recent articles on Plectasin Most cited articles on Plectasin Review articles on Plectasin Articles on Plectasin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Plectasin Images of Plectasin Photos of Plectasin Podcasts & MP3s on Plectasin Videos on Plectasin
Evidence Based Medicine
Cochrane Collaboration on Plectasin Bandolier on Plectasin TRIP on Plectasin
Clinical Trials
Ongoing Trials on Plectasin at Clinical Trials.gov Trial results on Plectasin Clinical Trials on Plectasin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Plectasin NICE Guidance on Plectasin NHS PRODIGY Guidance FDA on Plectasin CDC on Plectasin
Books
Books on Plectasin
News
Plectasin in the news Be alerted to news on Plectasin News trends on Plectasin
Commentary
Blogs on Plectasin
Definitions
Definitions of Plectasin
Patient Resources / Community
Patient resources on Plectasin Discussion groups on Plectasin Patient Handouts on Plectasin Directions to Hospitals Treating Plectasin Risk calculators and risk factors for Plectasin
Healthcare Provider Resources
Symptoms of Plectasin Causes & Risk Factors for Plectasin Diagnostic studies for Plectasin Treatment of Plectasin
Continuing Medical Education (CME)
CME Programs on Plectasin
International
Plectasin en Espanol Plectasin en Francais
Business
Plectasin in the Marketplace Patents on Plectasin
Experimental / Informatics
List of terms related to Plectasin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Plectasin is a new antibiotic found by Novozymes in the mushroom Pseudoplectania nigrella. Plectasin belongs to the antimicrobial peptide class called Defensins. Tests on mice have shown promising results that multiresistant bacteria have problems mutating resistance against Plectasin, however development and registration of a product are still 7 to 10 years off.

External links

• Novozymes, company press release on Plectasin
• bio.com, article on the findings